thromboxanes has been researched along with Atherogenesis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steg, G | 1 |
| Ardizzone, S; Aronico, N; Balduini, A; Corazza, GR; Davì, G; Di Sabatino, A; Giuffrida, P; Guerci, M; Gurini, E; Liani, R; Malara, A; Massari, A; Santilli, F; Simeone, P; Tripaldi, R | 1 |
| Cyrus, T; Ding, T; Praticò, D | 1 |
| Baumgärtel-Allekotte, D; Fischer, J; Heim, Kh; Kaber, G; Kaiser, B; Nagy, N; Nossmann, S; Rauch, B; Schrör, K; Weber, A | 1 |
| Knights, KM; Mangoni, AA | 1 |
| Belton, O; Fitzgerald, D; Harhen, B; Roche, HM; Toomey, S | 1 |
| Bhatt, DL; Meadows, TA | 1 |
| Day, CA; Jacob, RF; Mason, RP; Walter, MF | 1 |
3 review(s) available for thromboxanes and Atherogenesis
| Article | Year |
|---|---|
[Non-steroidal anti-inflammatory drugs and risk of stroke in older patients: current controversies and research directions].
Topics: Age Factors; Aged; Aged, 80 and over; Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Comorbidity; Cyclooxygenase 2 Inhibitors; Disease Progression; Drug Interactions; Edema; Epoprostenol; Evidence-Based Medicine; Forecasting; Humans; Hypertension; Kidney; Research; Risk; Stroke; Thrombophilia; Thromboxanes | 2011 |
Clinical aspects of platelet inhibitors and thrombus formation.
Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Pentanoic Acids; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, PAR-1; Stents; Tetrazoles; Thrombosis; Thromboxanes; Ticlopidine | 2007 |
A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAids.
Topics: Atherosclerosis; Cell Membrane; Cyclooxygenase 2 Inhibitors; Humans; Lactones; Lipid Peroxidation; Lipoproteins, LDL; Naproxen; Prostaglandins I; Risk Factors; Sulfones; Thromboxanes | 2007 |
5 other study(ies) available for thromboxanes and Atherogenesis
| Article | Year |
|---|---|
[Antiplatelet agents].
Topics: Atherosclerosis; Humans; Phosphodiesterase Inhibitors; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Thrombosis; Thromboxanes | 2013 |
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; CD40 Ligand; Colitis, Ulcerative; Crohn Disease; Female; Gastrointestinal Agents; Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Infliximab; Lipid Peroxidation; Male; Megakaryocytes; Middle Aged; Oxidative Stress; Platelet Activation; Thromboxanes; Tumor Necrosis Factor-alpha; Young Adult | 2016 |
Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: correlation with plaque composition.
Topics: Animals; Atherosclerosis; Cytochrome P-450 Enzyme System; Dietary Fats; Gene Expression Regulation, Enzymologic; Immunohistochemistry; Intramolecular Oxidoreductases; Lipids; Male; Mice; Mice, Knockout; Prostaglandins; Receptors, Thromboxane; Reverse Transcriptase Polymerase Chain Reaction; Thromboxane-A Synthase; Thromboxanes | 2010 |
Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbit.
Topics: Animal Feed; Animals; Aorta; Aspirin; Atherosclerosis; Cholesterol; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Antagonism; Epoprostenol; Female; Fibrinolytic Agents; Immunohistochemistry; Lactones; Male; Platelet Aggregation Inhibitors; Rabbits; Sulfones; Thrombosis; Thromboxanes | 2011 |
Profound resolution of early atherosclerosis with conjugated linoleic acid.
Topics: Animals; Aorta; Apoptosis; Atherosclerosis; Blood Platelets; Cell Line; Cholesterol; Eicosanoids; Epoprostenol; Homozygote; Humans; Linoleic Acids, Conjugated; Macrophages; Mice; Mice, Inbred C57BL; Mice, Transgenic; Monocytes; Peroxisome Proliferator-Activated Receptors; Thromboxanes; Triglycerides | 2006 |